GSK 37.5 (Paroxetine Extended-Release 37.5 mg)
Pill imprint GSK 37.5 has been identified as Paroxetine hydrochloride extended-release 37.5 mg.
Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; social anxiety disorder; panic disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. There is positive evidence of human fetal risk during pregnancy. Paroxetine 37.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GSK 37.5 (Paroxetine Extended-Release 37.5 mg)
- 37.5 mg
- Prescription only
- Drug Class:
- Selective serotonin reuptake inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium lauryl sulfate
More about paroxetine
- Paroxetine capsules
- Paroxetine controlled-release tablets
- Paroxetine mesylate
- Paroxetine suspension
- Paroxetine (Advanced Reading)